miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7.

Journal of Cellular and Molecular Medicine
Shiqi KongZongmao Zhao

Abstract

A generally used chemotherapeutic drug for glioma, a frequently diagnosed brain tumour, is temozolomide (TMZ). Our study investigated the activity of FBXL7 and miR-152-5p in glioma. Levels of microRNA-152-5p (miR-152-5p) and the transcript and protein of FBXL7 were assessed by real-time PCR and Western blotting, respectively. The migratory and invasive properties of cells were measured by Transwell migration and invasion assay and their viability were examined using CCK-8 assay. Further, the putative interaction between FBXL7 and miR-152-5p were analysed bioinformatically and by luciferase assay. The activities of FBXL7, TMZ and miR-152-5p were analysed in vivo singly or in combination, on mouse xenografts, in glioma tumorigenesis. The expression of FBXL7 in glioma tissue is significantly up-regulated, which is related to the poor prognosis and the grade of glioma. TMZ-induced cytotoxicity, proliferation, migration and invasion in glioma cells were impeded by the knock-down of FBXL7 or overexpressed miR-152-5p. Furthermore, the expression of miR-152-5p reduced remarkably in glioma cells and it exerted its activity through targeted FBXL7. Overexpression of miR-152-5p and knock-down of FBXL7 in glioma xenograft models enhanced TM...Continue Reading

References

Apr 19, 2002·Nature·Ning ZhengNikola P Pavletich
May 15, 2002·Current Biology : CB·Mariana Lagos-QuintanaThomas Tuschl
Feb 20, 2008·Cell Division·Dimple R Bosu, Edward T Kipreos
Feb 19, 2011·Biochemical and Biophysical Research Communications·Guan JiangJun-Nian Zheng
Mar 26, 2013·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Chuan-Ming XieYi Sun
Sep 27, 2014·Development·Mariana Rodrigues-Campos, Barry J Thompson
Jun 18, 2016·Oncology Letters·Xuexiang LiuShengming Dai
Jun 18, 2017·Molecular Cancer Therapeutics·Jingshan TongLin Zhang
Jul 20, 2017·Development·Chiara Alberti, Luisa Cochella
Nov 17, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Suzanne DufresneDarren R Brenner
Jun 15, 2018·Neurologia Medico-chirurgica·Yutaro YamamotoArata Tomiyama
Jun 16, 2018·International Journal of Biological Sciences·Wendao YouRui Li
Jul 10, 2018·Briefings in Bioinformatics·Liang ChenGarry Wong
Sep 20, 2018·Nature Reviews. Molecular Cell Biology·Thomas TreiberGunter Meister
Sep 27, 2018·Neurologia Medico-chirurgica·Shabierjiang JiapaerMitsutoshi Nakada
Feb 20, 2019·Frontiers in Oncology·Paul DanielBassam S Abdulkarim
Aug 15, 2019·Oncology Reviews·Sanjib BahadurSuman Saha
Oct 11, 2019·Journal of Cancer·Hao ZhangFan Fan
Nov 22, 2019·Oncolytic Virotherapy·Juri Kiyokawa, Hiroaki Wakimoto
Nov 23, 2019·Acta neurochirurgica·Michael Müther, Walter Stummer
Nov 30, 2019·Frontiers in Oncology·Chao ZhangXiang-Yu Ma
Dec 7, 2019·NeuroImage. Clinical·Adomas BuneviciusSamuel Patz

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay
Protein Assay
transfection
xenograft

Software Mentioned

Quantity One
GraphPad Prism

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.